GetTopicDetailResponse(id=4c5c1612239, topicName=Selumetinib治療, introduction=Selumetinib治療, content=null, image=null, comments=0, allHits=745, url=https://h5.medsci.cn/topic?id=16122, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=8618, tagList=[TagDto(tagId=8618, tagName=Selumetinib治療)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2244463, encodeId=6c2122444638a, content=<a href='/topic/show?id=4c5c1612239' target=_blank style='color:#2F92EE;'>#Selumetinib治療#</a> <a href='/topic/show?id=6fbb122699cf' target=_blank style='color:#2F92EE;'>#神經(jīng)纖維瘤1型#</a>, objectTitle=Neuro Oncol：Selumetinib在神經(jīng)纖維瘤1型（NF1）患者中的療效與安全性評估, objectType=article, longId=856512, objectId=83cb8565125c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240618/1718704912124_92910.png, objectUrl=/article/show_article.do?id=83cb8565125c, replyNumber=0, likeNumber=49, createdTime=2024-12-23, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=83cb8565125c, moduleTitle=Neuro Oncol：Selumetinib在神經(jīng)纖維瘤1型（NF1）患者中的療效與安全性評估, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=83cb8565125c)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
